)
)
Blau Farmacêutica Investor Relations Material
Latest events
Q2 2024
Blau Farmacêutica
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Blau Farmacêutica S.A
Access all reports
Blau Farmacêutica S.A manufactures and commercializes generic drugs in Brazil, Colombia, Uruguay, Chile, and internationally. The company operates through Institutional and Retail segments. It offers medications covering various therapeutic classes, including immunology, hematology, oncology, nephrology, specialties, and antibiotics. The company is based in Brazil
Key slides for Blau Farmacêutica S.A
Q1 2024
Blau Farmacêutica S.A
Q1 2024
Blau Farmacêutica S.A
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
BLAU3
Country
🇧🇷 Brazil